Catalase Protects Cardiomyocyte Function in Models of Type 1 and Type 2 Diabetes

Diabetes

Volumn 53, Issue 5, 2004, Pages 1336-1343

  Ye, Gang ^a   Metreveli, Naira S ^a   Donthi, Rajakumar V ^a   Xia, Shen ^a   Xu, Ming ^a   Carlson, Edward C ^b   Epstein, Paul N ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CATALASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SUCCINATE DEHYDROGENASE (UBIQUINONE); THENOYLTRIFLUOROACETONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CARDIOMYOPATHY; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME INHIBITION; ENZYME MECHANISM; GENE INDUCTION; GENE OVEREXPRESSION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MUSCLE FIBRIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ANIMALS; CALCIUM; CATALASE; CYTOPROTECTION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION; INTRACELLULAR MEMBRANES; MALONDIALDEHYDE; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; REACTIVE OXYGEN SPECIES;

EID: 2342563763     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.5.1336     Document Type: Article

References (30)

1. Jaffe AS, Spadaro JJ, Schechtman K, Roberts R, Geltman EM, Sobel BE: Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 108:31-37, 1984
2. Brown RA, Walsh MF, Ren J. Influence of gender and diabetes on vascular and myocardial contractile function. Endocr Res 27:399-408, 2001
3. Belke DD, Larsen TS, Gibbs EM, Severson DL: Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 279:E1104-E1113, 2000
4. Ren J, Sowers JR, Walsh MF, Brown RA: Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. Am J Physiol Heart Circ Physiol 279: H1708-H1714, 2000
5. Fein FS: Diabetic cardiomyopathy (Review). Diabetes Care 13:1169-1179, 1990
6. Zarich SW, Nesto RW: Diabetic cardiomyopathy. Am Heart J 118:1000-1012, 1989
7. Marra G, Cotroneo P, Pitocco D, Manto A, Di Leo MA, Ruotolo V, Caputo S, Giardina B, Ghirlanda G, Santini SA: Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 25:370-375, 2002
8. Penckofer S, Schwertz D, Florczak K: Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J Cardiovasc Nurs 16:68-85, 2002
9. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
10. Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN: Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51:174-181, 2002
11. Ye G, Metreveli NS, Ren J, Epstein PN: Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52:777-783, 2003
12. Kang YJ, Zhou ZX, Wu H, Wang GW, Saari JT, Klein JB: Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab Invest 80:745-757, 2000
13. DeMoor JM, Koropatnick DJ: Metals and cellular signaling in mammalian cells. Cell Mol Biol (Noisy-le-grand). 46:367-381, 2000
14. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED: Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109:629-639, 2002
15. Epstein PN, Overbeek PA, Means AR: Calmodulin-induced early-onset diabetes in transgenlc mice. Cell 58:1067-1073, 1989
16. Kang YJ, Chen Y, Yu A, Voss-McCowan M, Epstein PN: Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 100:1501-1506, 1997
17. Liang Q, Carlson EC, Borgerding AJ, Epstein PN: A transgenic model of acetaldehyde overproduction accelerates alcohol cardiomyopathy. J Pharmacol Exp Ther 291:766-772, 1999
18. Karnovsky MJ: A formaldehyde-glutaraldehyde fixative for high osmololity for use in electron microscopy. J Cell Biol 35:137A-138A, 1965
19. Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A, Anversa P: IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50:1414-1424, 2001
20. Wohaieb SA, Godin DV: Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat: effects of insulin treatment. Diabetes 36:1014-1018, 1987
21. Nishio Y, Taki H, Hidaka H, Kashiwagi A: Altered NF-kB activity and oxidative stress-related gene expression in cardiovascular tissues of diabetic rats. Diabetes 46 (Suppl. 1):A206, 1997
22. Genet S, Kale RK, Baquer NZ: Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonellafoenum graecum). Mol Cell Biochem 236:7-12, 2002
23. Wohaieb SA, Godin DV: Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat. Can J Physiol Pharmacol 65:2191-2195, 1987
24. Brand MD: Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp Gerontol 35:811-820, 2000
25. Du X-L, Edelstein D, Brownlee M: Free fatty acids inhibit endothelial cell prostacyclin production and nitric oxide synthetase (eNOS) activity by inducing mitochondrial superoxide overproduction (Abstract). Diabetes 50 (Suppl. 2):A152, 2001
26. DiMauro S, Hirano M: Mitochondria and heart disease. Curr Opin Cardiol 13:190-197, 1998
27. Giacomelli F, Wiener J: Primary myocardial disease in the diabetic mouse: an ultrastructural study. Lab Invest 40:460-473, 1979
28. Lesnefsky EJ, Gudz TI, Migita CT, Ikeda-Saito M, Hassan MO, Turkaly PJ, Hoppel CL: Ischemic injury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys 385:117-128, 2001
29. Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT: Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273:11619-11624, 1998
30. Dutta K, Podolin DA, Davidson MB, Davidoff AJ: Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 50:1186-1192, 2001